Literature DB >> 10334758

Economics notes: measuring outcomes in economic evaluations.

D Torgerson1, J Raftery.   

Abstract

Mesh：

Year:  1999        PMID： 10334758      PMCID： PMC1115785          DOI： 10.1136/bmj.318.7195.1413

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  6 in total

Review 1.  Economics notes: types of economic evaluation.

Authors:  S Palmer; S Byford; J Raftery
Journal:  BMJ       Date:  1999-05-15

2.  EuroQol--a new facility for the measurement of health-related quality of life.

Authors: 
Journal:  Health Policy       Date:  1990-12       Impact factor: 2.980

3.  Assessing the benefits of health care: how far should we go?

Authors:  M Ryan; P Shackley
Journal:  Qual Health Care       Date:  1995-09

4.  Using willingness to pay to assess the benefits of assisted reproductive techniques.

Authors:  M Ryan
Journal:  Health Econ       Date:  1996 Nov-Dec       Impact factor: 3.046

5.  A study of the natural history of back pain. Part I: development of a reliable and sensitive measure of disability in low-back pain.

Authors:  M Roland; R Morris
Journal:  Spine (Phila Pa 1976)       Date:  1983-03       Impact factor: 3.468

6.  The SF36 health survey questionnaire: an outcome measure suitable for routine use within the NHS?

Authors:  A M Garratt; D A Ruta; M I Abdalla; J K Buckingham; I T Russell
Journal:  BMJ       Date:  1993-05-29
  6 in total
  10 in total

1.  Measuring outcomes in economic evaluations. This economics note is misleading.

Authors:  S Dixon; C Green
Journal:  BMJ       Date:  1999-09-11

2.  An introduction to economic evaluation.

Authors:  S Goodacre; C McCabe
Journal:  Emerg Med J       Date:  2002-05       Impact factor: 2.740

3.  Being economical with the truth: how to make your idea appear cost effective.

Authors:  S Goodacre; C McCabe
Journal:  Emerg Med J       Date:  2002-07       Impact factor: 2.740

4.  Towards more consistent use of generic quality-of-life instruments.

Authors:  Mattias Neyt
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

5.  Cost effectiveness analysis of intravenous ketorolac and morphine for treating pain after limb injury: double blind randomised controlled trial.

Authors:  T H Rainer; P Jacobs; Y C Ng; N K Cheung; M Tam; P K Lam; R Wong; R A Cocks
Journal:  BMJ       Date:  2000-11-18

Review 6.  Conceptualising 'Benefits Beyond Health' in the Context of the Quality-Adjusted Life-Year: A Critical Interpretive Synthesis.

Authors:  Lidia Engel; Stirling Bryan; David G T Whitehurst
Journal:  Pharmacoeconomics       Date:  2021-08-23       Impact factor: 4.981

7.  Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts.

Authors:  Dany Habka; David Mann; Ronald Landes; Alejandro Soto-Gutierrez
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

8.  Alexander Technique Lessons, Acupuncture Sessions or usual care for patients with chronic neck pain (ATLAS): study protocol for a randomised controlled trial.

Authors:  Hugh MacPherson; Helen E Tilbrook; Stewart J Richmond; Karl Atkin; Kathleen Ballard; Martin Bland; Janet Eldred; Holly N Essex; Ann Hopton; Harriet Lansdown; Usman Muhammad; Steve Parrott; David Torgerson; Aniela Wenham; Julia Woodman; Ian Watt
Journal:  Trials       Date:  2013-07-10       Impact factor: 2.279

9.  What is the value of social values? The uselessness of assessing health-related quality of life through preference measures.

Authors:  Luis Prieto; José A Sacristán
Journal:  BMC Med Res Methodol       Date:  2004-04-29       Impact factor: 4.615

10.  An economic evaluation of Alexander Technique lessons or acupuncture sessions for patients with chronic neck pain: A randomized trial (ATLAS).

Authors:  Holly Essex; Steve Parrott; Karl Atkin; Kathleen Ballard; Martin Bland; Janet Eldred; Catherine Hewitt; Ann Hopton; Ada Keding; Harriet Lansdown; Stewart Richmond; Helen Tilbrook; David Torgerson; Ian Watt; Aniela Wenham; Julia Woodman; Hugh MacPherson
Journal:  PLoS One       Date:  2017-12-06       Impact factor: 3.240
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.